Professor, University of Colorado Hospital
Radiation Oncology
Dr. Rachel Rabinovitch, MD
|
|
Give Review
Doctor Rachel Rabinovitch, MD is an expert in the field of Radiation Oncology. She attended Albert Einstein College of Medicine of Yeshiva University. She over the years received 5 awards: "America's Top Doctors", "America's Top Doctors for Cancer", "CMS Meaningful Use Stage 1 Certification", "CORE Magazine" and "Redbook Magazine: Top Breast Cancer Doctors". Rachel Rabinovitch is a published doctor as well. She has 12 publications published. The latest was: 21-Gene Recurrence Score Assay As a Predictor of Adjuvant Chemotherapy Administration for Early-Stage Breast Cancer: An Analysis of Use, Therapeutic Implications, and ... Rachel Rabinovitch accepts all Medicare patients.
Publications
- Improved Survival with Combined Modality Therapy in the Modern Era for Primary Mediastinal B-Cell Lymphoma.
- The Impact of Postmastectomy and Regional Nodal Radiation after Neoadjuvant Chemotherapy for Clinically Lymph Node Positive Breast Cancer: A National Cancer Database (...
- Improved Survival With Radiation Therapy in Stage I-II Primary Mediastinal B Cell Lymphoma: A Surveillance, Epidemiology, and End Results Database Analysis.
- Frontiers in Radiotherapy for Early-Stage Invasive Breast Cancer.
- Improved Cosmesis in Early Breast Cancer Using Conformal Radiotherapy.
- Management of male breast cancer in the United States: a surveillance, epidemiology and end results analysis.
- RTOG 95-17, a Phase II trial to evaluate brachytherapy as the sole method of radiation therapy for Stage I and II breast carcinoma-year-5 toxicity and cosmesis.
- A detailed evaluation of TomoDirect 3DCRT planning for whole-breast radiation therapy.
- American College of Radiology (ACR) and American Society for Radiation Oncology (ASTRO) Practice Guideline for the Performance of Total Body Irradiation (TBI).
- Outcomes and effect of radiotherapy in patients with stage I or II diffuse large B-cell lymphoma: a surveillance, epidemiology, and end results analysis.
- 21-Gene Recurrence Score Assay As a Predictor of Adjuvant Chemotherapy Administration for Early-Stage Breast Cancer: An Analysis of Use, Therapeutic Implications, and ...
Schools
Albert Einstein College of Medicine of Yeshiva University
Staten Island University Hospital Program
Memorial SloanKettering Cancer Center Program
Doctors Specialties
- Radiation Oncology
Accepted Insurances
Awards
- America's Top Doctors
- America's Top Doctors for Cancer
- CMS Meaningful Use Stage 1 Certification
- CORE Magazine
- Redbook Magazine: Top Breast Cancer Doctors
Education
-
Memorial Sloan-Kettering Cancer Center -
Staten Island University Hospital -
Albert Einstein College of Medicine of Yeshiva University
Hospital
-
University of Colorado Hospital
Drug Facts
| NPI NUMBER | 1164539904 | |
| NPPES Provider LastName | RABINOVITCH | |
| NPPES Provider FirstName | RACHEL | |
| NPPES Provider ZIPCode | 800452545 | |
| NPPES Provider State | CO | |
| Specialty Description | Radiation Oncology | |
| Total Claim Count | 63.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1164539904 |
| Last Name Of The Provider | RABINOVITCH |
| First Name Of The Provider | RACHEL |
| View All |
Similar Doctors
|
Dr. David Raben, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
Dr. Laurie E. Gaspar, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. Arthur K. Liu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christine M. Fisher, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brian D. Kavanagh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tracey Schefter, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Krishna Reddy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Chad G. Rusthoven, MD |